Сравнительная оценка эффективности комбинированной терапии иммуномодуляторами и антибиотиком при хроническом течении реактивного артрита, ассоциированного с хламидийной инфекцией

Алексеева Екатерина Иосифовна, Е С Жолобова, Saniya I Valieva · CyberLeninK (CyberLeninka) · 2005

The study was aimed at a comparative evaluation of the efficacy of combined therapy with immunomodulators and an antibiotic (roxithromycin) in reactive arthritis associated with chronic chlamydian infection in children. Of 58 patients with chronic reactive arthritis associated with chlamydian infection 20 patients (basic group) received Licopid; the reference group 20 children -received Tactivin (first reference group); another 18 patients Polyoxidonium (second reference group). In all patients markers of active chlamydian infection (antibodies in synovial fluid and blood serum; antigens in synovial fluid, in epithelial cells of the urethra and conjunctiva) were detected. The groups were clinically and demographically comparable. An analysis of the findings showed that 6 months after the termination of treatment the indices of activity of inflammatory process were lower in all groups of patients. However, the most effective was the combination of Licopid with roxithromycin: a clinical-laboratory remission and etiologic cure were obtained in 75% of children of this group (in the first reference group in 55%, in the second reference group in 66% of patients). The use of immunomodulators in combination with antibiotics for treating chronic reactive arthritis associated with chlamydian infection is pathogenetically justified. Combined therapy results in remission of the joint syndrome and eradication of the causative agent from biological media.

Cited by 0 works.

Authors